Extensive studies have reported that ASF1B is significantly upregulated in tumor tissues and promotes progression of various cancers, including prostate cancer, cervical cancer, and clear cell renal cell carcinoma (41–43), but there has been no previous report of its role in HCC. This evidence concerns the gene ASF1B and Familial prostate cancer.